About this trial
The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult females or males age ≥ 40 years
Ability to read and speak English
Disqualifiers
Current use of a dietary supplement containing fulvic or humic acid
Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella
Known allergies to any ingredients in the product
Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
Trial design
Single group
Treatments tested in this trial
Humic and Fulvic Acid Dietary Supplement
Dietary supplementBioToxin Binder (CellCore Biosciences, Palm Beach Gardens, FL) - Humic and Fulvic Acid Dietary Supplement
Treatment groups
Trial outcomes
Primary outcomes
TruDiagnostic - Epigenetic Testing
TruAge Test